Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Gland Pharma IPO.
November 9, 2020 2:30:00 AM
Gland Pharma is one of the biggest pharma IPOs. The company has a focus on complex injectables which has high entry barriers and strategic partnerships to penetrate new markets like China ...
Published by : MintNovember 4, 2020 9:42:00 AM
The IPO of Hyderabad-based Gland Pharma will open on November 9 and close on November 11. The company plans to raise up to ?1,250 crore through issue of fresh equity shares up to 34.8 lakh.
Published by : Business Insider IndiaNovember 9, 2020 10:28:00 AM
The recent geopolitical tension between India and China remains a big risk factor, and may not play out well for Gland Pharma. The ?6,500 IPO of Hyderabad-based Gland Pharma is now open for ...
Published by : Business Insider IndiaApril 10, 2024 1:08:00 AM
At around 9:26 a.m., shares of Gland Pharma traded 5.95 per cent, or Rs 110.7, lower on BSE at 1,751 apiece. The company's market capitalisation stood at Rs 28,857.28 crore at around the same time.
Published by : Zee BusinessJuly 25, 2024 12:08:00 PM
On July 23, the Hyderabad-based company received tentative US FDA approval for Latanoprostene Bunod Ophthalmic Solution, 0.025%. This eye drop is used to reduce elevated intraocular pressure in ...
Published by : ndtvprofitJuly 22, 2024 7:20:00 PM
Gland Pharma Ltd share price was up by 0.21% from the previous closing price of ?1,990.60. Who are peers of Gland Pharma Ltd? The peers of Gland Pharma Ltd are Sun Pharmaceuticals Industries Ltd ...
Published by : Business TodayJuly 25, 2024 5:49:00 PM
Akums Drug IPO has reserved not more than 75% of the shares in the ... are Divi's Laboratories (with a P/E of 74.99), Suven Pharma (with a P/E of 69.54), Gland Pharma (with a P/E of 42.45), Torrent ...
Published by : MintJuly 25, 2024 3:16:00 PM
Danam's registration statement named several former executives of the $10 billion retail pharmacy franchise of pharma heavyweight McKesson.
Published by : The Business JournalsJune 30, 2024 3:29:00 AM
Gland Pharma on November 6 reported a 19.56 percent year-on-year (YoY) fall in consolidated net profit to Rs 194 crore for the July-September quarter of the current financial year. The company ...
Published by : moneycontrol.comJuly 19, 2024 6:30:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Published by : MorningstarJuly 9, 2024 1:58:00 PM
Emcure Pharmaceuticals IPO allotment has been finalised. The Emcure Pharma IPO allotment date was scheduled for Monday, July 8. For those who have been allocated shares, the crediting of shares to ...
Published by : MSNJuly 8, 2024 6:33:07 AM
Emcure Pharma IPO allotment status can be checked online on the Link Intime website -- the registrar. Emcure Pharma IPO GMP or latest grey market premium is around 40 per cent.
Published by : ET Now on MSNThe IPO Shares of Gland Pharma Limited IPO are proposed to list on Friday, November 20, 2020 at BSE, NSE. The public issue of Gland Pharma IPO was opened on Nov 9, 2020 and closed for subscription on Nov 11, 2020. Gland Pharma IPO Listing Date and Information:
| Listing Date | Friday, November 20, 2020 |
| BSE Script Code | 543245 |
| NSE Symbol | GLAND |
| Listing In | |
| ISIN | INE068V01023 |
| Issue Price | [.] |
| Face Value | Rs 1 Per Equity Share |
The allotment status of Gland Pharma Limited IPO is now available online. The public issue of Gland Pharma IPO was open on Nov 9, 2020 and closed for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE.
Gland Pharma Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 1 aggregating up to Rs [.] Crore. The price for the issue has been set at Rs 1490 - Rs 1500 Per Equity Share.
Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.
The issue opens on Nov 9, 2020 and closes for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE.
The issue of Gland Pharma Limited opens on Nov 9, 2020 and closes for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 1490 - Rs 1500 Per Equity Share.
The Gland Pharma IPO is proposed to open on November 9, 2020. The IPO application ends on November 11, 2020.
Retail investors can apply in the retail or non-institutional investor category from November 9, 2020 to November 11, 2020. The Gland Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Gland Pharma IPO will open for subscription on November 9, 2020. The public issue will close on November 11, 2020.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
